Biotech R&D (NAICS 541714) in South Carolina 1st District (SC-01)
USAspending.gov tags $2,793,575,807 to Research And Development In Biotechnology (Except Nanobiotechnology) inside South Carolina 1st District (SC-01) — 7 award records, not outlays. Seven biotechnology-R&D awards equal about twenty-eight percent of South Carolina 1st District's published obligation book — a thin 541714 file with a high implied mean. That pair is Research And Development In Biotechnology (Except Nanobiotechnology) and South Carolina 1st District (SC-01) — not South Carolina's entire federal inflow, not Research And Development In Biotechnology (Except Nanobiotechnology) nationwide, and not cash already paid. The cell is 28.1% of this district's published obligation total ($9,958,570,081.46). Implied average obligation is about $399,082,258.14 ($2,793,575,807 ÷ 7). Correlation is not causation.
Key figures
- Biotech R&D in South Carolina 1st District (SC-01): $2,793,575,807 across 7 USAspending awards.
- Implied mean about $399,082,258.14 per record; district share 28.1% of $9,958,570,081.46.
- NAICS 541714 × SC-01 is an obligation join, not an outlay and not a named-recipient list.
- Cite USAspending.gov; quote South Carolina 1st District and NAICS 541714 if live tables moved.
- South Carolina federal spending and All spending ties are parents and an index, not amounts to add into $2,793,575,807.
Biotech R&D obligations coded to South Carolina 1st District (SC-01)
NAICS 541714 and congressional district SC-01 meet here. $2,793,575,807 is the USAspending.gov obligation sum on awards that carry both tags. It is not the nationwide Research And Development In Biotechnology (Except Nanobiotechnology) total, not every federal dollar coded to South Carolina 1st District (SC-01), and not an outlay register. The packet does not split therapeutic from other 541714 biotechnology R&D, and it does not split contract versus assistance. 7 is an action count: modifications and repeat awards add rows. Unique recipients are unpublished. This cell is not a clinical-trial registry, a named-lab file, or a nanobiotechnology (541713) book.
Dividing $2,793,575,807 by 7 yields about $399,082,258.14 per award on average. That ratio is two packet facts. It is not a typical contract, grant, or benefit line. Seven awards against a two-point-eight-billion-dollar 541714 cell is extreme concentration. Do not read 7 as seven named labs or seven clinical trials. Do not treat SC-01's 541714 cell as a synonym for every Biotech R&D account nationwide. Open South Carolina 1st District for the district table without this industry filter, NAICS 541714 for NAICS 541714 without a SC-01 filter, South Carolina federal spending for every industry in the South Carolina extract, and All spending ties for the rest of the join list. Quote those hubs as parents, not as addends to $2,793,575,807.
What Biotech R&D contributes to this pair
USAspending labels industry 541714 as Research And Development In Biotechnology (Except Nanobiotechnology). That code produced $2,793,575,807 when crossed with South Carolina 1st District (SC-01) place of performance. The industry-wide 541714 hub does not require SC-01 geography. The district hub does not require Biotech R&D. Only this tie applies both filters, which is why it cites 7 awards. The packet does not split therapeutic from other 541714 biotechnology R&D, and it does not split contract versus assistance.
Correlation is not causation: South Carolina 1st District (SC-01) did not cause $2,793,575,807 by existing as a large or small place. Population, outcome scores, and named facilities are not packet facts. The join is 541714 × SC-01 only. This cell is not a clinical-trial registry, a named-lab file, or a nanobiotechnology (541713) book. Do not invent contractors or award recipients to fill the gap. Campaign donations on FEC tables do not fund this USAspending cell; the datasets are separate.
District geography versus South Carolina statewide totals
South Carolina 1st District (SC-01) on this join is a USAspending geography field, not a claim that every dollar was disbursed to residents of that district. Awards can list SC-01 while later work occurs elsewhere. Awards tagged to other South Carolina districts belong on those ties even when the industry is also 541714. South Carolina 1st District (SC-01) is a numbered congressional place-of-performance code inside South Carolina. Other South Carolina districts are separate joins even when they reuse NAICS 541714. South Carolina 1st District (SC-01) is not South Carolina 6th. SC-06 hosts engineering services (541330) in this harvest, not biotechnology R&D.
South Carolina federal spending shows how NAICS 541714 sits beside other industries in the same state extract. $2,793,575,807 is one district-industry column, not the state table. This packet does not split South Carolina 1st District (SC-01) by county, city, or census tract. Awards that carry a different NAICS stay on those other ties even if the work sounds related to Research And Development In Biotechnology (Except Nanobiotechnology). The district-wide obligation total published here is $9,958,570,081.46; $2,793,575,807 is the Biotech R&D slice of that denominator.
Why this is not an outlay register
USAspending.gov records an obligation when the federal government commits funds on an award. $2,793,575,807 is that kind of sum for Research And Development In Biotechnology (Except Nanobiotechnology) inside SC-01 coding. Later deobligations, recoveries, or payment schedules can change what leaves the Treasury without this join rewriting itself into a cash register. Assistance and contract awards can share the same industry rollup; this packet does not split them. Net obligations can include downward adjustments. This page reports $2,793,575,807 as given.
South Carolina's own budget is a separate ledger. Mixing it with the 7-row Biotech R&D cell leaves USAspending.gov. Treat 7 as award records in the aggregate, not unique vendors. Do not annualize without a year field in the packet. Do not per-capita or per-recipient the dollar total; those denominators are unpublished. The implied mean ($399,082,258.14) is a concentration statistic, not a typical SC-01 Biotech R&D payment.
Live tables versus this snapshot
Cite USAspending.gov: Research And Development In Biotechnology (Except Nanobiotechnology) (NAICS 541714) obligated $2,793,575,807 on 7 awards coded to South Carolina 1st District (SC-01). Name Research And Development In Biotechnology (Except Nanobiotechnology) and South Carolina 1st District (SC-01) together. Keep the obligation word. If South Carolina 1st District or NAICS 541714 has refreshed, prefer the live hub over this snapshot for current rows. The pair is not a clinical-trial registry, a named-lab file, or a nanobiotechnology (541713) book. 28.1% of $9,958,570,081.46 is the district share on this packet, not a performance score.
Keep Research And Development In Biotechnology (Except Nanobiotechnology), South Carolina 1st District (SC-01), $2,793,575,807, and 7 awards together. All spending ties indexes other pairs. NAICS 541714 is the 541714 parent without a SC-01 filter. South Carolina federal spending is the South Carolina parent. Do not add those parents to this cell. Sharing a district with Biotech R&D does not mean campaign donations funded these awards, and it does not convert obligations into outlays. This page reports one USAspending join.
What this packet refuses to infer
Seven awards against a two-point-eight-billion-dollar 541714 cell is extreme concentration. Do not read 7 as seven named labs or seven clinical trials. Nanobiotechnology is excluded by the NAICS title. Trial registries and investigator names are unpublished. Do not add SC-06 engineering dollars into this cell. A large row count makes a product split tempting; the packet still does not supply one. A small row count makes a named-facility story tempting; the packet still does not name facilities or contractors. The implied mean (about $399,082,258.14) and the district share (28.1% of $9,958,570,081.46) are ratios of packet facts. Prefer South Carolina 1st District and NAICS 541714 if the live tables moved.
Questions
- How much Biotech R&D spending is coded to South Carolina 1st District (SC-01)?
- USAspending.gov lists $2,793,575,807 in Research And Development In Biotechnology (Except Nanobiotechnology) obligations across 7 awards with place of performance in South Carolina 1st District (SC-01). NAICS 541714 × SC-01 is an obligation join, not an outlay and not South Carolina's complete federal ledger. The cell is 28.1% of the district's published total ($9,958,570,081.46). Unique recipients are unpublished. Average obligation is about $399,082,258.14, a ratio of those two facts only.
- Does $2,793,575,807 include every Biotech R&D product line in SC-01?
- The packet publishes one NAICS rollup. The packet does not split therapeutic from other 541714 biotechnology R&D, and it does not split contract versus assistance. $2,793,575,807 is the combined obligation sum for NAICS 541714 inside SC-01 coding. This page will not invent a product pie or name contractors. Open NAICS 541714 and South Carolina 1st District to inspect parent tables. 7 remains an action count, not a product count.
- Is $2,793,575,807 cash already paid in South Carolina 1st District (SC-01)?
- No. Obligations are commitments recorded on USAspending.gov awards. Outlays — money that actually left the Treasury — are a different concept and are not this packet's headline. Treating $2,793,575,807 as checks already cleared in South Carolina 1st District (SC-01) confuses those terms. Later ingests can revise 7 awards. Prefer the live district and industry hubs if the tables moved.
- What share of SC-01 obligations is NAICS 541714?
- NAICS 541714 accounts for 28.1% of $9,958,570,081.46 in district-wide obligations on this packet. That share is $2,793,575,807 ÷ $9,958,570,081.46. It is not a ranking of South Carolina districts and not an outlay share. Other industries occupy the remaining district total on other ties.
USAspending.gov congressional district place-of-performance joined to NAICS industry. Obligations are not outlays.